KRAS and Patent ductus arteriosus: The QM-PDA category demonstrated an association with elevated tumor grade and unfavorable survival outcomes, while the classical subtype exhibited the presence of the endodermal lineage-specifying transcription factor GATA6 and showcased dependency on KRAS.20